AgeX Therapeutics, Inc. (AGE) SEC filings
AGE SEC filings moved a median of +0.38% by the close. AGE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AGE overview →
25 measured AGE SEC filing events.
Where these AGE SEC filings landedvs 24 measured AGE SEC filing reactions
| Middle 50% of AGE SEC filing reactions | -5.63% to +3.30% |
|---|---|
| Median reaction (to close) | +0.38% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 AGE SEC filing events with a measured close landed between -5.63% and +3.30%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K AgeX Therapeutics, Inc. For: Mar 26 | SEC filing · Form 8-K | — | — | |
| Form 10-K AgeX Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -0.71% | |
| Form 8-K AgeX Therapeutics, Inc. For: Mar 22 | SEC filing · Form 8-K | — | -0.71% | |
| Form 8-K AgeX Therapeutics, Inc. For: Mar 14 | SEC filing · Form 8-K | — | +38.29% | |
| Form 8-K AgeX Therapeutics, Inc. For: Mar 05 | SEC filing · Form 8-K | +0.39% | -0.26% | |
| Form 8-K AgeX Therapeutics, Inc. For: Feb 09 | SEC filing · Form 8-K | +0.00% | +1.78% | |
| Form EFFECT AgeX Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | +0.77% | |
| Form S-4/A AgeX Therapeutics, Inc. | SEC filing · Form S-4 | — | -8.22% | |
| Form 8-K AgeX Therapeutics, Inc. For: Feb 01 | SEC filing · Form 8-K | — | -8.22% | |
| Form 8-K AgeX Therapeutics, Inc. For: Jan 16 | SEC filing · Form 8-K | +0.00% | +5.13% | |
| Form S-4/A AgeX Therapeutics, Inc. | SEC filing · Form S-4 | +0.00% | +1.79% | |
| Form 8-K AgeX Therapeutics, Inc. For: Jan 08 | SEC filing · Form 8-K | +0.00% | +1.00% | |
| Form 8-K AgeX Therapeutics, Inc. For: Jan 03 | SEC filing · Form 8-K | -0.31% | -8.54% | |
| Form 8-K AgeX Therapeutics, Inc. For: Dec 21 | SEC filing · Form 8-K | +0.00% | +3.25% | |
| Form 8-K AgeX Therapeutics, Inc. For: Dec 13 | SEC filing · Form 8-K | +4.69% | +8.50% | |
| Form 8-K AgeX Therapeutics, Inc. For: Dec 05 | SEC filing · Form 8-K | +0.80% | +0.00% | |
| Form 8-K AgeX Therapeutics, Inc. For: Nov 27 | SEC filing · Form 8-K | -5.14% | -5.40% | |
| Form 8-K AgeX Therapeutics, Inc. For: Nov 15 | SEC filing · Form 8-K | -9.24% | -13.07% | |
| Form DEF 14A AgeX Therapeutics, Inc. For: Nov 14 | SEC filing · Form DEF | — | -7.18% | |
| Form 10-Q AgeX Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.67% | -5.63% | |
| Form 8-K AgeX Therapeutics, Inc. For: Nov 14 | SEC filing · Form 8-K | +1.67% | -5.63% | |
| Form S-4 AgeX Therapeutics, Inc. | SEC filing · Form S-4 | +16.38% | +3.45% | |
| Form DEF 14A AgeX Therapeutics, Inc. For: Nov 07 | SEC filing · Form DEF | +0.00% | +8.91% | |
| Form DEFA14A AgeX Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | +8.91% | |
| Form 8-K AgeX Therapeutics, Inc. For: Oct 31 | SEC filing · Form 8-K | +0.00% | +1.25% |
Keep exploring
More AGE: earnings → · analyst actions → · AGE overview →